This website is being reviewed for updates. Some information is offline. We apologize for any inconvenience.
Skip to main content
Rural Health Information Hub

Geographic Variation and Racial Disparities in Adoption of Newer Glucose-Lowering Drugs with Cardiovascular Benefits among US Medicare Beneficiaries with Type 2 Diabetes

Description
Analyzes the use of glucose-lowering drugs (GLDs) among people with type 2 diabetes, utilizing 2017-2018 Medicare Part D beneficiary claims data. Identifies rural-urban and racial disparities in GLD initiation rates, and discusses factors influencing equitable access to cardiovascular treatment.
Author(s)
Wei-Han Chen, Yujia Li, Lanting Yang, et al.
Citation
Plos ONE, 19(1), e0297208
Date
01/2024
Type
Document
Tagged as
Access · Cardiovascular disease · Diabetes · Health disparities · Pharmacy and prescription drugs · Racial and ethnic groups · Rural-urban differences · Statistics and data